Berry Genomics Co.,Ltd. Posted 13.8 Million Yuan Net Loss in First Three Quarters of 2022

Berry Genomics Co.,Ltd. (成都市贝瑞和康基因技术股份有限公司) (000710.SZ) reported a net loss of 13.8 million yuan in the first three quarters of 2022, reversing a net profit of 28.1 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.1 billion yuan in revenue, down 5.3% year-on-year.

At the end of the reporting period, it had 3.3 billion yuan in total assets and 819.5 million yuan in total liabilities, with a liability-to-asset ratio of 24.6%.